President Donald Trump’s Food and Drug Administration (FDA) is moving to end animal testing practices involving beagles, ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
Non-animal testing methods could save drugmakers time and money, officials say ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of ...
HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...
The way we test new medicines in the U.S. is about to change. The FDA is officially moving away from animal testing and embracing new technologies that rely on human cells and artificial intelligence.
(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...
Animal models work in lab conditions, because their lives are shorter so you can control the environment in studies.